GGrantIndex
Sort

46,585 grants matching heart failure

Regulation of neurotransmitter properties by target-derived neurotrophic factors

$392,100
Susan J Birren · Brandeis University · R01 · FY2009 · NS

Integrating Costs Into Shared Decision-Making for Heart Failure with Reduced Ejection Fraction

$392,083
Neal Workman Dickert · Emory University · R01 · FY2020 · HS

Pannexin 1 in Regulation of Adipose Tissue Inflammation

$392,045
Norbert Leitinger · University Of Virginia · P01 · FY2014 · HL

Pannexin 1 in Regulation of Adipose Tissue Inflammation

$392,045
Norbert Leitinger · University Of Virginia · P01 · FY2018 · HL

Pannexin 1 in Regulation of Adipose Tissue Inflammation

$392,045
Norbert Leitinger · University Of Virginia · P01 · FY2016 · HL

Pannexin 1 in Regulation of Adipose Tissue Inflammation

$392,045
Norbert Leitinger · University Of Virginia · P01 · FY2017 · HL

Molecular Control of Myo/Angiogenesis

$392,041
Kenneth Walsh · Boston University Medical Campus · R01 · FY2009 · HL

Molecular Control of Myo/Angiogenesis

$392,041
Kenneth Walsh · Boston University Medical Campus · R01 · FY2008 · HL

Project 3: Early detection and prevention of MM progression

$392,040
Marta Chesi · Mayo Clinic Arizona · P50 · FY2023 · CA

Skeletal FGF23 production mediated by GPCR/Gq/PKC signaling

$392,025
Murat Bastepe · Massachusetts General Hospital · R01 · FY2024 · DK

Mechanisms Underlying Regulation of PLCbeta by heterotrimeric G proteins

$392,016
Angeline Marie Lyon · Purdue University · R01 · FY2025 · GM

Role of VEGF in Perinatal Hypertension

$392,009
Steven Herbert Abman · University Of Colorado Denver · R01 · FY2015 · HL

Novel Therapeutic Approaches to Atrial Fibrillation Targeting Intracellular Calci

$392,000
Andrew R Marks · Columbia University Health Sciences · R01 · FY2014 · HL

Molecular Basis of Heart Failure

$392,000
Andrew R Marks · Columbia University Health Sciences · R01 · FY2014 · HL

Molecular Imaging of the Lung Using Hyperpolarized Carbon-13 Compounds

$392,000
Rahim R Rizi · University Of Pennsylvania · R01 · FY2014 · HL

Predicting and preventing drug metabolism by the human gut microbiome

$391,963
Peter James Turnbaugh · University Of California, San Francisco · R01 · FY2016 · HL

Direct Methanol Fuel Cell Artificial Heart Power Supply

$391,955
Lynntech, Inc. · R44 · FY2001 · HL

Adjustable and Measurable Ventricular Restraint for Heart Failure

$391,952
Frederick Y Chen · Brigham And Women'S Hospital · R01 · FY2009 · HL

Cardiac fibrosis is regulated by protein turnover in the endoplasmic reticulum

$391,875
Randy T Cowling · University Of California, San Diego · R01 · FY2018 · HL

PROJECT III

$391,860
Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · P50 · FY2007 · GM

Maternal Microchimerism and Neonatal Tolerance

$391,828
William J Burlingham · University Of Wisconsin-Madison · R01 · FY2012 · AI

Protection against Doxorubicin-Induced Cardiomyopathy

$391,825
Rakesh C. Kukreja · Virginia Commonwealth University · R37 · FY2014 · HL

Global Circuitry that Controls Acinetobacter Resistance and Virulence

$391,810
Edward Geisinger · Northeastern University · R01 · FY2023 · AI

Global Circuitry that Controls Acinetobacter Resistance and Virulence

$391,810
Edward Geisinger · Northeastern University · R01 · FY2022 · AI

Whole genome DNA sequencing to identify novel genes in dilated cardiomyopathy

$391,713
Matthew R Taylor · University Of Colorado Denver · R01 · FY2014 · HL